Utilize the data and tweets at hand to foresee if the closing price of $jnj will elevate or diminish at 2017-09-27. Only answer with Rise or Fall.
Context: date,open,high,low,close,adj-close,inc-5,inc-10,inc-15,inc-20,inc-25,inc-30
2017-09-13,0.2,1.0,-0.5,-0.1,-0.1,-0.1,-0.6,-0.5,-0.3,-0.3,-0.3
2017-09-14,-1.5,0.2,-1.6,1.3,1.3,-1.1,-1.7,-1.7,-1.6,-1.5,-1.5
2017-09-15,0.3,0.7,-0.2,0.2,0.2,-0.8,-1.7,-1.8,-1.7,-1.6,-1.7
2017-09-18,-0.7,0.3,-0.9,0.7,0.7,-1.2,-2.1,-2.3,-2.3,-2.2,-2.3
2017-09-19,-0.1,0.4,-0.6,-0.1,-0.1,-0.7,-1.5,-2.0,-2.0,-2.0,-2.1
2017-09-20,0.0,0.8,-0.7,-1.5,-1.5,1.0,0.1,-0.5,-0.6,-0.5,-0.6
2017-09-21,1.2,1.6,-0.3,-1.1,-1.1,1.7,1.2,0.7,0.5,0.5,0.5
2017-09-22,0.5,0.8,-0.1,-0.3,-0.3,1.5,1.5,0.9,0.8,0.8,0.8
2017-09-25,0.2,0.4,-0.3,-0.2,-0.2,1.1,1.5,1.1,0.9,0.9,0.9
2017-09-26,0.4,0.8,-0.1,-0.2,-0.2,0.6,1.6,1.3,1.1,1.0,1.1

2017-09-13: #jnj group ww chair sandi peterson receives corporate citizenship award at AT_USER distinguished performance awa¡­ |rt AT_USER $spx $nasdaq $djia $cac $dax $ftse $jpm $tsla $es_f $cl_f $gc_f $tlt $wmt
2017-09-14: the single best investment: creating wealth with dividend growth by lowell miller:  $jnj $pg $hd $t $vz|btw, estimated #earnings per share for $jnj is $1.73 it's 1.31% of the current price |$jnj etfs 
2017-09-15: traders sell shares of johnson &amp; johnson $jnj on strength $jnj |no $efx mauldin found! $msft's found! $baba $crm $goog $brk $ibm $snap $jpm $bac $jnj $goog $twtr $orcl $iep $f $ba¡­ |rt AT_USER la
2017-09-16: $jnj moves away from hep c due to rival drugmakers' cures |rt AT_USER all kidding aside, i need a job &amp; fast $aapl $amzn $brk $crm $cmg $ko $dis $twx $vrx $agn $pep $ibm $msft $hlf $jnj $hd $go¡­|
2017-09-17: **update** $jnj breakout setup here $xlp #trade2017 |good technicals, but also a nice setup pattern forming for $jnj   #insurance #online |champions! $vrx $agn $myl $mrk $ko $pep $ibm $dis $crm $cmg $
2017-09-18: rt AT_USER added $jnj dec 135/oct 13 exp 138 call diagonals for $3.24 (oct 13 is pre-earnings)|#johnsonjohnson portland's sightbox sold to health care behemoth. read more:  $jnj|$jnj's tremfya was app
2017-09-19: rt AT_USER on the evaporating moats of cpg from the horse's mouth, $jnj consumer. |rt AT_USER on the evaporating moats of cpg from the horse's mouth, $jnj consumer. |rt AT_USER on the evaporating moat
2017-09-20: rt AT_USER $pfe cries foul as its first biosimilar limps in u.s. market; files suit in federal court citing $jnj¡¯s exclusionary contract¡­|rt AT_USER on the evaporating moats of cpg from the horse's 
2017-09-21: buy on close order imbalances  $pg $xom $jnj $tjx $sre $dwdp $ko $tsm $$bxwt $m $usg $dte $ppl $q $avy $ha: $eog |evening most tweeted big caps, check out gambiste top 10: $jnj $v $vz $msft $xom $chtr
2017-09-22: $jnj: johnson &amp; johnson's janssen receives complete response letter from the fda for sirukumab biologics license... |biotech's friday price and volume moves -   $exel $agn $mrk $bmy $jnj $vsar $ic
2017-09-23: rt AT_USER $fgen #roxadustat #anemia straight-forward&amp;simple:does all things $amgn $jnj  $6b epo drugs (esas) do but in an easy-to-admi¡­|rt AT_USER $jnj, $myl represent pharma on fortune's latest
2017-09-24: rt AT_USER johnson &amp; johnson: 42 (-0.48%)  $jnj #johnsonjohnson #sentiment #stock #analysis #bigdata|rt AT_USER johnson &amp; johnson: 42 (-0.48%)  $jnj #johnsonjohnson #sentiment #stock #analysis
2017-09-25: $jnj vp says device industry not well suited to randomized controlled trials #medtechcon|$jnj lines up its 4-in-1 #hiv pill for #fda behind rivals from $gild, $gsk #pharma |the fda panel voted 12-1 ag
2017-09-26: $ flows: buying on weakness: among stocks that were down tue-these had the largest net inflows of money $lqd $gdx¡­ |rt AT_USER $acrx acelrx pharmaceuticals inc (nasdaq:acrx) could still have a lot of
Answer:
Utilize the data and tweets at hand to foresee if the closing price of $jnj will elevate or diminish at 2017-09-27. Only answer with Rise or Fall.
Context: date,open,high,low,close,adj-close,inc-5,inc-10,inc-15,inc-20,inc-25,inc-30
2017-09-13,0.2,1.0,-0.5,-0.1,-0.1,-0.1,-0.6,-0.5,-0.3,-0.3,-0.3
2017-09-14,-1.5,0.2,-1.6,1.3,1.3,-1.1,-1.7,-1.7,-1.6,-1.5,-1.5
2017-09-15,0.3,0.7,-0.2,0.2,0.2,-0.8,-1.7,-1.8,-1.7,-1.6,-1.7
2017-09-18,-0.7,0.3,-0.9,0.7,0.7,-1.2,-2.1,-2.3,-2.3,-2.2,-2.3
2017-09-19,-0.1,0.4,-0.6,-0.1,-0.1,-0.7,-1.5,-2.0,-2.0,-2.0,-2.1
2017-09-20,0.0,0.8,-0.7,-1.5,-1.5,1.0,0.1,-0.5,-0.6,-0.5,-0.6
2017-09-21,1.2,1.6,-0.3,-1.1,-1.1,1.7,1.2,0.7,0.5,0.5,0.5
2017-09-22,0.5,0.8,-0.1,-0.3,-0.3,1.5,1.5,0.9,0.8,0.8,0.8
2017-09-25,0.2,0.4,-0.3,-0.2,-0.2,1.1,1.5,1.1,0.9,0.9,0.9
2017-09-26,0.4,0.8,-0.1,-0.2,-0.2,0.6,1.6,1.3,1.1,1.0,1.1

2017-09-13: #jnj group ww chair sandi peterson receives corporate citizenship award at AT_USER distinguished performance awa¡­ |rt AT_USER $spx $nasdaq $djia $cac $dax $ftse $jpm $tsla $es_f $cl_f $gc_f $tlt $wmt
2017-09-14: the single best investment: creating wealth with dividend growth by lowell miller:  $jnj $pg $hd $t $vz|btw, estimated #earnings per share for $jnj is $1.73 it's 1.31% of the current price |$jnj etfs 
2017-09-15: traders sell shares of johnson &amp; johnson $jnj on strength $jnj |no $efx mauldin found! $msft's found! $baba $crm $goog $brk $ibm $snap $jpm $bac $jnj $goog $twtr $orcl $iep $f $ba¡­ |rt AT_USER la
2017-09-16: $jnj moves away from hep c due to rival drugmakers' cures |rt AT_USER all kidding aside, i need a job &amp; fast $aapl $amzn $brk $crm $cmg $ko $dis $twx $vrx $agn $pep $ibm $msft $hlf $jnj $hd $go¡­|
2017-09-17: **update** $jnj breakout setup here $xlp #trade2017 |good technicals, but also a nice setup pattern forming for $jnj   #insurance #online |champions! $vrx $agn $myl $mrk $ko $pep $ibm $dis $crm $cmg $
2017-09-18: rt AT_USER added $jnj dec 135/oct 13 exp 138 call diagonals for $3.24 (oct 13 is pre-earnings)|#johnsonjohnson portland's sightbox sold to health care behemoth. read more:  $jnj|$jnj's tremfya was app
2017-09-19: rt AT_USER on the evaporating moats of cpg from the horse's mouth, $jnj consumer. |rt AT_USER on the evaporating moats of cpg from the horse's mouth, $jnj consumer. |rt AT_USER on the evaporating moat
2017-09-20: rt AT_USER $pfe cries foul as its first biosimilar limps in u.s. market; files suit in federal court citing $jnj¡¯s exclusionary contract¡­|rt AT_USER on the evaporating moats of cpg from the horse's 
2017-09-21: buy on close order imbalances  $pg $xom $jnj $tjx $sre $dwdp $ko $tsm $$bxwt $m $usg $dte $ppl $q $avy $ha: $eog |evening most tweeted big caps, check out gambiste top 10: $jnj $v $vz $msft $xom $chtr
2017-09-22: $jnj: johnson &amp; johnson's janssen receives complete response letter from the fda for sirukumab biologics license... |biotech's friday price and volume moves -   $exel $agn $mrk $bmy $jnj $vsar $ic
2017-09-23: rt AT_USER $fgen #roxadustat #anemia straight-forward&amp;simple:does all things $amgn $jnj  $6b epo drugs (esas) do but in an easy-to-admi¡­|rt AT_USER $jnj, $myl represent pharma on fortune's latest
2017-09-24: rt AT_USER johnson &amp; johnson: 42 (-0.48%)  $jnj #johnsonjohnson #sentiment #stock #analysis #bigdata|rt AT_USER johnson &amp; johnson: 42 (-0.48%)  $jnj #johnsonjohnson #sentiment #stock #analysis
2017-09-25: $jnj vp says device industry not well suited to randomized controlled trials #medtechcon|$jnj lines up its 4-in-1 #hiv pill for #fda behind rivals from $gild, $gsk #pharma |the fda panel voted 12-1 ag
2017-09-26: $ flows: buying on weakness: among stocks that were down tue-these had the largest net inflows of money $lqd $gdx¡­ |rt AT_USER $acrx acelrx pharmaceuticals inc (nasdaq:acrx) could still have a lot of
Answer:+Fall